Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AVNS logo AVNS
Upturn stock ratingUpturn stock rating
AVNS logo

Avanos Medical Inc (AVNS)

Upturn stock ratingUpturn stock rating
$12.24
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: AVNS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $14

1 Year Target Price $14

Analysts Price Target For last 52 week
$14Target price
Low$11.75
Current$12.24
high$25.36

Analysis of Past Performance

Type Stock
Historic Profit -29.5%
Avg. Invested days 31
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 564.64M USD
Price to earnings Ratio -
1Y Target Price 14
Price to earnings Ratio -
1Y Target Price 14
Volume (30-day avg) 1
Beta 1.14
52 Weeks Range 11.75 - 25.36
Updated Date 06/29/2025
52 Weeks Range 11.75 - 25.36
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) -8.27

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -55.8%
Operating Margin (TTM) 6.15%

Management Effectiveness

Return on Assets (TTM) 2.26%
Return on Equity (TTM) -36.78%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 608538995
Price to Sales(TTM) 0.82
Enterprise Value 608538995
Price to Sales(TTM) 0.82
Enterprise Value to Revenue 0.88
Enterprise Value to EBITDA 17.17
Shares Outstanding 46244000
Shares Floating 45368581
Shares Outstanding 46244000
Shares Floating 45368581
Percent Insiders 3.8
Percent Institutions 96.06

Analyst Ratings

Rating 1
Target Price 14
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Avanos Medical Inc

stock logo

Company Overview

overview logo History and Background

Avanos Medical, Inc. was formerly part of Kimberly-Clark Corporation's healthcare business. It was spun off as an independent company in November 2014. Its roots trace back to the early 20th century through predecessor companies involved in medical devices and technologies.

business area logo Core Business Areas

  • Chronic Care: This segment develops, manufactures, and markets medical devices for pain management, respiratory health, and digestive health.
  • Acute Pain: This segment offers non-opioid pain management solutions, focused on regional anesthesia and acute pain therapies.

leadership logo Leadership and Structure

Joe Woody serves as the Chief Executive Officer. The company operates with a functional organizational structure, divided into segments based on product categories and support functions like R&D, Sales, and Marketing.

Top Products and Market Share

overview logo Key Offerings

  • COOLIEF* Cooled Radiofrequency: A minimally invasive pain management solution targeting chronic pain. Competitors include Halyard Health (acquired by Owens & Minor), Medtronic. Market share is variable depending on specific indications and regions, but Avanos is a key player in cooled RF. Specific revenue figures are not publicly broken down.
  • ON-Q* Pain Relief System: A non-opioid pain relief system that delivers local anesthetic. Competitors include Pacira BioSciences (EXPAREL). Specific revenue figures are not publicly available.
  • MIC-KEY* Feeding Tubes: Gastrostomy tubes used for enteral feeding. Competitors include Applied Medical Technology, Boston Scientific. Revenue figures and market share are not publicly broken down.

Market Dynamics

industry overview logo Industry Overview

The medical device industry is characterized by innovation, regulation, and consolidation. Growing demand for minimally invasive procedures and non-opioid pain management options drives market growth. Technological advancements and increasing aging populations fuel demand for advanced medical technologies.

Positioning

Avanos is positioned as a provider of minimally invasive pain management and chronic care solutions. Its competitive advantage lies in its portfolio of non-opioid pain management therapies and established presence in specific market niches.

Total Addressable Market (TAM)

The global pain management devices market is estimated to reach USD 6.3 Billion by 2033. Avanos Medical Inc. has a strong presence in this market. The global enteral feeding devices market is estimated to reach USD 4.44 billion by 2031.

Upturn SWOT Analysis

Strengths

  • Focus on minimally invasive and non-opioid solutions
  • Established brand recognition in specific product categories
  • Strong relationships with healthcare providers
  • Diversified product portfolio across chronic and acute care

Weaknesses

  • Reliance on a limited number of key products
  • Exposure to regulatory changes and reimbursement pressures
  • Competition from larger medical device companies
  • Potential impact of product recalls or liability claims

Opportunities

  • Expansion into new geographic markets
  • Development of innovative products and technologies
  • Strategic acquisitions to broaden product portfolio
  • Increased adoption of non-opioid pain management therapies

Threats

  • Intense competition from established players
  • Technological obsolescence
  • Economic downturns impacting healthcare spending
  • Unfavorable regulatory changes or pricing pressures

Competitors and Market Share

competitor logo Key Competitors

  • Medtronic (MDT)
  • Boston Scientific (BSX)
  • Pacira BioSciences (PCRX)
  • Owens & Minor (OMI)

Competitive Landscape

Avanos faces competition from larger medical device companies with greater resources. Avanos's advantage lies in its specialized products and focus on specific market niches. Success requires continuous innovation and strong execution.

Major Acquisitions

Bard Site Rite Vision Technology

  • Year: 2017
  • Acquisition Price (USD millions): 80
  • Strategic Rationale: Expanded vascular access offerings.

Growth Trajectory and Initiatives

Historical Growth: Historical growth has been driven by organic sales growth and acquisitions. Growth rates vary depending on economic conditions and market trends.

Future Projections: Future growth projections depend on analyst estimates and company guidance. Projections are subject to change based on market conditions.

Recent Initiatives: Recent strategic initiatives include product launches, acquisitions, and cost-reduction programs.

Summary

Avanos Medical operates in a competitive medical device market, focusing on pain management and chronic care. They have a diversified product portfolio and are focused on non-opioid solutions. Their smaller size compared to larger competitors necessitates consistent innovation and strategic acquisitions to sustain growth. The company's success depends on navigating regulatory landscapes and demonstrating clinical value for their offerings. Avanos needs to watch out for larger companies encroaching on its specialized markets.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Avanos Medical Inc. Investor Relations
  • Company SEC Filings (10-K, 10-Q)
  • Industry Reports (e.g., Market Research Reports)
  • Analyst Reports
  • Company Website

Disclaimers:

The information provided is for informational purposes only and should not be considered investment advice. Market data and analyst estimates are subject to change. Please consult with a qualified financial advisor before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Avanos Medical Inc

Exchange NYSE
Headquaters Alpharetta, GA, United States
IPO Launch date 2014-10-21
CEO -
Sector Healthcare
Industry Medical Devices
Full time employees 2227
Full time employees 2227

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; OrthogenRx knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.